Noxopharm gets HERACLES autoimmune trials started with first human doses
Noxopharm Ltd (ASX:NOX) has got its HERACLES trials out the gates in Week 29, dosing a preliminary patient in the first-in-human use of its SOF-SKN topical drug candidate targeting TLR7/8 for autoimmune diseases.Listen to the HotCopper podcast for in-depth discussions and insights on all the bigg...
The Watchlist
Previous Video
Next Video
HAR
HARANGA RESOURCES LIMITED.
Peter Batten, MD
Peter Batten
MD
Previous Video
Next Video
SPONSORED BY The Market Online